Table 3.
Candidate variables | Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | Model 6 | Model 7 |
---|---|---|---|---|---|---|---|
CASA-Q cough impact | <0.0001 | <0.0001 | <0.0001 | ||||
CASA-Q cough symptoms | 0.0435 | NS | 0.00012 | ||||
CASA-Q sputum impact | 0.0581 | NS | <0.0001 | ||||
CASA-Q sputum symptoms | NS | NS | 0.0020 | ||||
FEV1, % | 0.0058 | 0.0024 | 0.00019 | 0.0072 | 0.0068 | 0.0042 | |
mMRC dyspnea scale | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
Exacerbations | 0.0334 | 0.0266 | 0.0028 | 0.0320 | 0.0046 | 0.0037 | |
Depression | 0.0558 | 0.0229 | 0.0037 | 0.0338 | 0.0080 | 0.0017 | |
Anxiety | 0.0889 | 0.0995 | 0.0331 | 0.0542 | 0.0169 | 0.0090 | |
Cardiovascular comorbidities | 0.0072 | 0.00043 | 0.0019 | 0.0167 | 0.0101 | 0.0068 | |
Chronic bronchitis | 0.0498 | ||||||
R2 | 0.38 | 0.60 | 0.62 | 0.56 | 0.58 | 0.54 | 0.54 |
Abbreviations: CASA-Q, cough and sputum assessment questionnaire; FEV1, forced expiratory volume in 1 second; mMRC, modified Medical Research Council dyspnea score from 0 to 4 with higher score indicating more severe dyspnea; NS, not significant; SGRQ, Saint George’s Respiratory Questionnaire ranging from 0 to 100 with lower score indicating more severe health-related quality of life impairment.